Shriram M. Pathak

698 total citations
20 papers, 394 citations indexed

About

Shriram M. Pathak is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Shriram M. Pathak has authored 20 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Shriram M. Pathak's work include Drug Solubulity and Delivery Systems (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Shriram M. Pathak is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Shriram M. Pathak collaborates with scholars based in India, United Kingdom and United States. Shriram M. Pathak's co-authors include David B. Turner, Masoud Jamei, N Udupa, Nikunjkumar Patel, Edmund Kostewicz, Prashant B Musmade, Krishnamurthy Bhat, Kerstin J. Schaefer, Joachim Brouwers and Patrick Augustijns and has published in prestigious journals such as Analytica Chimica Acta, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Shriram M. Pathak

19 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shriram M. Pathak India 11 219 87 78 73 66 20 394
Jef Stappaerts Belgium 12 301 1.4× 88 1.0× 111 1.4× 96 1.3× 98 1.5× 22 492
Andrés Olivares‐Morales Switzerland 11 134 0.6× 87 1.0× 137 1.8× 56 0.8× 76 1.2× 19 501
Philippe Berben Belgium 10 279 1.3× 94 1.1× 108 1.4× 91 1.2× 73 1.1× 11 434
Benjamin Wuyts Belgium 7 214 1.0× 104 1.2× 56 0.7× 77 1.1× 54 0.8× 11 341
Danny Riethorst Belgium 9 259 1.2× 112 1.3× 89 1.1× 67 0.9× 66 1.0× 12 447
Jens Van Den Αbeele Belgium 10 233 1.1× 53 0.6× 58 0.7× 52 0.7× 45 0.7× 10 422
Mark D. Coffin United States 6 219 1.0× 105 1.2× 78 1.0× 28 0.4× 33 0.5× 9 423
Matthew Crum Australia 5 309 1.4× 86 1.0× 76 1.0× 81 1.1× 81 1.2× 5 432
Maria Vertzoni Greece 9 272 1.2× 74 0.9× 73 0.9× 81 1.1× 72 1.1× 11 404
Cord J. Andreas Germany 7 252 1.2× 68 0.8× 47 0.6× 73 1.0× 64 1.0× 9 373

Countries citing papers authored by Shriram M. Pathak

Since Specialization
Citations

This map shows the geographic impact of Shriram M. Pathak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shriram M. Pathak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shriram M. Pathak more than expected).

Fields of papers citing papers by Shriram M. Pathak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shriram M. Pathak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shriram M. Pathak. The network helps show where Shriram M. Pathak may publish in the future.

Co-authorship network of co-authors of Shriram M. Pathak

This figure shows the co-authorship network connecting the top 25 collaborators of Shriram M. Pathak. A scholar is included among the top collaborators of Shriram M. Pathak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shriram M. Pathak. Shriram M. Pathak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Brouwers, Joachim, et al.. (2022). Practical and operational considerations related to paediatric oral drug formulation: An industry survey. International Journal of Pharmaceutics. 618. 121670–121670. 16 indexed citations
3.
Parrott, Neil, Sandra Suarez‐Sharp, Filippos Kesisoglou, et al.. (2020). Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report. Journal of Pharmaceutical Sciences. 110(2). 584–593. 19 indexed citations
4.
Stamatopoulos, Konstantinos, Shriram M. Pathak, Luca Marciani, & David B. Turner. (2020). Population-Based PBPK Model for the Prediction of Time-Variant Bile Salt Disposition within GI Luminal Fluids. Molecular Pharmaceutics. 17(4). 1310–1323. 8 indexed citations
5.
Harwood, Matthew D., et al.. (2019). The Regional-Specific Relative and Absolute Expression of Gut Transporters in Adult Caucasians: A Meta-Analysis. Drug Metabolism and Disposition. 47(8). 854–864. 32 indexed citations
6.
Pathak, Shriram M., et al.. (2018). Heat Transfer Augmentation in Heat Exchanger using Nanofluid: A Review. International Journal of Trend in Scientific Research and Development. Volume-2(Issue-3). 1939–1944. 1 indexed citations
7.
Pathak, Shriram M., Kerstin J. Schaefer, Masoud Jamei, & David B. Turner. (2018). Biopharmaceutic IVIVE—Mechanistic Modeling of Single- and Two-Phase In Vitro Experiments to Obtain Drug-Specific Parameters for Incorporation Into PBPK Models. Journal of Pharmaceutical Sciences. 108(4). 1604–1618. 39 indexed citations
8.
Hens, Bart, Shriram M. Pathak, Amitava Mitra, et al.. (2017). In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole. Molecular Pharmaceutics. 14(12). 4321–4333. 63 indexed citations
9.
10.
Pathak, Shriram M., et al.. (2014). Critical attributes of transdermal drug delivery system (TDDS) – a generic product development review. Drug Development and Industrial Pharmacy. 40(11). 1421–1428. 21 indexed citations
11.
Pathak, Shriram M., Deepika Aggarwal, & Vobalaboina Venkateswarlu. (2013). Establishment ofin vitro–in vivoequivalence of highly variable drugs – a generic product development perspective. Pharmaceutical Development and Technology. 19(4). 401–410. 2 indexed citations
12.
Pathak, Shriram M., et al.. (2011). Analysis of Midazolam in Small Volumes of Plasma Using High Performance Liquid Chromatography and UV-Detection Method: Pharmacokinetics of Midazolam in Rats. Asian Journal of Research in Chemistry. 4(3). 406–414. 1 indexed citations
13.
14.
Ballal, Nidambur Vasudev, et al.. (2011). Evaluation of Chemical Interactions of Maleic Acid with Sodium Hypochlorite and Chlorhexidine Gluconate. Journal of Endodontics. 37(10). 1402–1405. 23 indexed citations
15.
Pathak, Shriram M., et al.. (2010). Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin—Preparation and in vitro and in vivo evaluation. European Journal of Pharmaceutical Sciences. 41(3-4). 440–451. 44 indexed citations
16.
Musmade, Prashant B, Praful Balavant Deshpande, Shriram M. Pathak, & Krishnamurthy Bhat. (2010). High Performance Liquid Chromatographic Method for the Determination of Clobetasol in Rat Plasma and its Application to Skin Penetration. Journal of Bioanalysis & Biomedicine. 2(1). 4 indexed citations
17.
Pathak, Shriram M. & N Udupa. (2010). Pre‐clinical evidence of enhanced oral bioavailability of the P‐glycoprotein substrate talinolol in combination with morin. Biopharmaceutics & Drug Disposition. 31(2-3). 202–214. 21 indexed citations
18.
Pathak, Shriram M., Prashant B Musmade, Krishnamurthy Bhat, & N Udupa. (2009). Validated HPLC Method for Quantitative Determination of Talinolol in Rat Plasma and Application to a Preclinical Pharmacokinetic Study. Bioanalysis. 2(1). 95–104. 6 indexed citations
19.
Arumugam, Karthik, et al.. (2008). Stability-indicating HPTLC determination of capsaicin in the bulk drug. Journal of Planar Chromatography – Modern TLC. 21(4). 271–275. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jef Stappaerts Breakdown of academic impact, for papers by Andrés Olivares‐Morales Breakdown of academic impact, for papers by Philippe Berben Breakdown of academic impact, for papers by Benjamin Wuyts Breakdown of academic impact, for papers by Danny Riethorst Breakdown of academic impact, for papers by Jens Van Den Αbeele Breakdown of academic impact, for papers by Mark D. Coffin Breakdown of academic impact, for papers by Matthew Crum Breakdown of academic impact, for papers by Maria Vertzoni Breakdown of academic impact, for papers by Cord J. Andreas
Rankless by CCL
2026